 |
|
 |
- May 11, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Biography |
|
|
Dr. Vasilis Tsimihodimos
Vasilis Tsimihodimos, MD
Department of Internal Medicine, Medical School, University of Ioannina, GR 45 100 Ioannina, Greece
Tel: +30 26510 97509, FAX: +30 26510 97016
E-mail: me00748@cc.uoi.gr
1997 Medical Diploma, Medical School, University of Ioannina, Greece
3/1997 - 6/1998 Compulsory G. P., Service of the Greek Provinces
7/1998 - 1/2000 Military Doctor in charge of a battalion of the Greek Army (National Service)
3/2004 Doctoral Diploma (Ph.D.) in Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece
1/2002- to date Resident in Internal Medicine, University Hospital of Ioannina, Ioannina, Greece
Membership Hellenic Atherosclerosis Society
Languages Greek (mother language), English.
LIST OF PUBLICATIONS
1. Tsimihodimos V, Miltiadous G, Daskalopoulou SS, Mikhailidis DP, Elisaf MS. Fenofibrate: metabolic and pleiotropic effects. Curr Vasc Pharmacol. 2005; 3: 87-98.
2. Tambaki AP, Rizos E, Tsimihodimos V, Tselepis AD, Elisaf M. Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.
J Cardiovasc Pharmacol Ther. 2004; 9:91-5.
3. Tsimihodimos V, Kostoula A, Kakafika A, Bairaktari E, Tselepis AD, Mikhailidis DP, Elisaf M. Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride values. J Cardiovasc Pharmacol Ther. 2004; 9:27-33.
4. Tsimihodimos V, Karabina SA, Tambaki A, Bairaktari E, Achimastos A, Tselepis A, Elisaf M. Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein subfractions in patients with dyslipidemias of type IIA and IIB. J Cardiovasc Pharmacol. 2003; 42: 304-10.
5. Kakafika AI, Xenofontos S, Tsimihodimos V, Tambaki AP, Lourida ES, Kalaitzidis R, Cariolou MA, Elisaf M, Tselepis AD. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
J Lipid Res. 2003; 44:1919-26.
6. Tsimihodimos V, Kakafika A, Tambaki AP, Bairaktari E, Chapman MJ, Elisaf M, Tselepis AD. Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.
J Lipid Res. 2003; 44:927-34.
7. Rizos E, Bairaktari E, Ganotakis E, Tsimihodimos V, Mikhailidis DP, Elisaf M. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes. J Cardiovasc Pharmacol Ther. 2002; 7:219-26.
8. Ganotakis E, Tsimihodimos V, Bairaktari E, Rizos E, Athyros V, Seferiades C, Elisaf M. Effects of various fibrates on serum alkaline phosphatase activity. Atherosclerosis. 2002; 165:187-8.
9. Liamis G, Kakafika A, Bairaktari E, Miltiadous G, Tsimihodimos V, Goudevenos J, Achimastos A, Elisaf M. Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia. Curr Med Res Opin. 2002; 18:125-8.
10. Tsimihodimos V, Miltiadous G, Bairaktari E, Elisaf M. Possible mechanisms of the fibrate-induced increase in serum creatinine. Clin Nephrol. 2002; 57:407-8.
11. Achimastos A, Liberopoulos E, Nikas S, Bairaktari E, Miltiadous G, Tsimihodimos V, Elisaf M. The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide. Curr Med Res Opin. 2002; 18:59-63.
12. Tsimihodimos V, Bairaktari E, Elisaf M. Fibrate-induced increase in serum urea and creatinine levels. Nephrol Dial Transplant. 2002; 17:682.
13. Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. J Lipid Res. 2002; 43:256-63.
14. Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB. Arterioscler Thromb Vasc Biol. 2002; 22:306-11.
15. Kakafika A, Tsimihodimos V, Elisaf M. Effect of atorvastatin on serum uric acid levels. Atherosclerosis. 2001; 158:255.
16. Miltiadous G, Tsimihodimos V, Bairaktari E, Elisaf M. Lipoprotein(a) levels in patients with homozygous familial hypercholesterolaemia. Atherosclerosis. 2001; 157:255-6.
17. Tsimihodimos V, Kakafika A, Elisaf M. Fibrate treatment can increase serum creatinine levels. Nephrol Dial Transplant. 2001; 16:1301.
18. Tsimihodimos V, Miltiadous G, Elisaf M. Therapy with statins is effective in some patients with homozygous familial hypercholesterolemia. Atherosclerosis. 2000; 153:527.
19. Tsimihodimos V, Kalaitzides R, Elisaf M. Hypouricemia in a patient with thyrotoxicosis. Eur J Endocrinol. 2001; 144:83.
20. Bairaktari E, Elisaf M, Katsaraki A, Tsimihodimos V, Tselepis AD, Siamopoulos KC, Tsolas O. Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patients. Clin Biochem. 1999; 32:339-46.
21. Elisaf M, Tsimichodimos V, Bairaktari E, Siamopoulos KC. Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia. J Cardiovasc Pharmacol. 1999; 34:60-3.
22. Bairaktari ET, Tzallas CS, Tsimihodimos VK, Liberopoulos EN, Miltiadous GA, Elisaf MS. Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia. J Cardiovasc Risk. 1999; 6:113-6.
23. Tsimihodimos V, Bairaktari E, Tzallas C, Miltiadus G, Liberopoulos E, Elisaf M. The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic. Thyroid. 1999; 9:365-8.
|
| |
List of presentations from this healthcare provider available on CMEonDiabetes :
 Disturbances of Phosphate Metabolism in Patients with Metabolic Syndrome
english - 2005-04-15 - 24 minutes
|
|
|
|
|
| Social |
 |
| |
Let others know about this biography.
|
|
| Search our website |
|
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
|
|
